<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Russo M</submitter><funding>European Research Council</funding><funding>Consortium ENHPATHY</funding><funding>Italian Association for Research on Cancer</funding><funding>Marie Sklodowska-Curie Action</funding><funding>Horizon 2020 European Training Network</funding><pagination>1017-1040</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10760643</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>37(21-24)</volume><pubmed_abstract>Transcription termination pathways mitigate the detrimental consequences of unscheduled promiscuous initiation occurring at hundreds of thousands of genomic &lt;i>cis&lt;/i>-regulatory elements. The Restrictor complex, composed of the Pol II-interacting protein WDR82 and the RNA-binding protein ZC3H4, suppresses processive transcription at thousands of extragenic sites in mammalian genomes. Restrictor-driven termination does not involve nascent RNA cleavage, and its interplay with other termination machineries is unclear. Here we show that efficient termination at Restrictor-controlled extragenic transcription units involves the recruitment of the protein phosphatase 1 (PP1) regulatory subunit PNUTS, a negative regulator of the SPT5 elongation factor, and Symplekin, a protein associated with RNA</pubmed_abstract><journal>Genes &amp; development</journal><pubmed_title>Restrictor synergizes with Symplekin and PNUTS to terminate extragenic transcription.</pubmed_title><pmcid>PMC10760643</pmcid><funding_grant_id>692789</funding_grant_id><funding_grant_id>860002</funding_grant_id><pubmed_authors>Polletti S</pubmed_authors><pubmed_authors>Russo M</pubmed_authors><pubmed_authors>Polizzese D</pubmed_authors><pubmed_authors>Piccolo V</pubmed_authors><pubmed_authors>Mandana GM</pubmed_authors><pubmed_authors>Bedin F</pubmed_authors><pubmed_authors>Rodighiero S</pubmed_authors><pubmed_authors>Natoli G</pubmed_authors><pubmed_authors>Borriero C</pubmed_authors><pubmed_authors>Marenda M</pubmed_authors><pubmed_authors>Michieletto D</pubmed_authors><pubmed_authors>Cuomo A</pubmed_authors><pubmed_authors>Prosperini E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Restrictor synergizes with Symplekin and PNUTS to terminate extragenic transcription.</name><description>Transcription termination pathways mitigate the detrimental consequences of unscheduled promiscuous initiation occurring at hundreds of thousands of genomic &lt;i>cis&lt;/i>-regulatory elements. The Restrictor complex, composed of the Pol II-interacting protein WDR82 and the RNA-binding protein ZC3H4, suppresses processive transcription at thousands of extragenic sites in mammalian genomes. Restrictor-driven termination does not involve nascent RNA cleavage, and its interplay with other termination machineries is unclear. Here we show that efficient termination at Restrictor-controlled extragenic transcription units involves the recruitment of the protein phosphatase 1 (PP1) regulatory subunit PNUTS, a negative regulator of the SPT5 elongation factor, and Symplekin, a protein associated with RNA</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Dec</publication><modification>2026-06-01T23:37:07.166Z</modification><creation>2026-05-23T03:08:04.016Z</creation></dates><accession>S-EPMC10760643</accession><cross_references><pubmed>38092518</pubmed><doi>10.1101/gad.351057.123</doi></cross_references></HashMap>